Major goals of the COBRE III Center are to increase the scope of research conducted in Montana related to zoonotic and emerging infectious diseases and to continue increasing the competitiveness of Montana investigators for extramural funding. One of the key components utilized during the past nine years to achieve these goals has been Pilot Project Programs, which have been part of the Adiministrative Core of our Phase I and Phase II grants. These programs have been instrumental in expanding the scope of the Center, accelerating productivity of collaborative studies, and increasing infectious disease grant funding in Montana. These achievements have significantly contributed to the growth of the COBRE Center and continue to foster its evolution into a sustainable Center at Montana State University. In Phase III, we propose an enhanced Pilot Grants Program so that it not only utilizes the best features identified during COBRE l/ll, but also includes improved elements to address any shortcomings of our prevoius programs. This enhanced Pilot Grants Program emphasizes collaborative, multidisciplinary, translational studies on zoonotic and emerging infectious diseases and includes extensive mentorship, guidance, and evaluation in order to develop these projects so that they can become competitive for major national research grants. To achieve these goals, the Specific Aims of the Pilot Grants Program are:
Specific Aim 1 : to increase the scope and impact of zoonotic and emerging infectious disease research conducted by our COBRE Center, Specific Aim 2: to increase support of collaborative studies that lead toward larger program-type grants, and Specific Aim 3: to increase utilization of Center Scientific Core research facilities. Proposals for Pilot Grants will be solicited on a yeariy basis using an request for applications (RFA) mechanism and will be reviewed by a panel consisting of the Steering Committee and External Advisory Committee members and other experts as needed. Awards will be for one year, with the possibility of renewal for a second year. The general criteria for selection will include: responsiveness to the solicitation specifications, likelihood the pilot studies will lead to longer term funding, excellence of the science, and alignment of the project with the mission of our COBRE Center. Based on our past record of success with Pilot Projects and the enhancements proposed under COBRE III, we feel confident that this program will significantly enhance the competitiveness of our research programs and contribute to the overall quality and impact of the COBRE Center.

Public Health Relevance

Pilot Grants represent an essential component ofthe COBRE III Center by expanding the scope and impact of our research. Through the use of an RFA and panel review mechanism, excellent projects focused on important questions in zoonotic and emerging infectious diseases and with high potential for future funding will be identified and supported.

National Institute of Health (NIH)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZGM1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Montana State University - Bozeman
United States
Zip Code
Giovannoni, Maria Paola; Schepetkin, Igor A; Crocetti, Letizia et al. (2016) Cinnoline derivatives as human neutrophil elastase inhibitors. J Enzyme Inhib Med Chem 31:628-39
Siemsen, Dan W; Dobrinen, Erin; Han, Soo et al. (2016) Vascular Dysfunction in Pneumocystis-Associated Pulmonary Hypertension Is Related to Endothelin Response and Adrenomedullin Concentration. Am J Pathol 186:259-69
Vergelli, Claudia; Schepetkin, Igor A; Ciciani, Giovanna et al. (2016) 2-Arylacetamido-4-phenylamino-5-substituted pyridazinones as formyl peptide receptors agonists. Bioorg Med Chem :
Cavigli, Ian; Daughenbaugh, Katie F; Martin, Madison et al. (2016) Pathogen prevalence and abundance in honey bee colonies involved in almond pollination. Apidologie 47:251-266
Schepetkin, Igor A; Ramstead, Andrew G; Kirpotina, Liliya N et al. (2016) Therapeutic Potential of Polyphenols from Epilobium Angustifolium (Fireweed). Phytother Res 30:1287-97
McMenamin, Alexander J; Brutscher, Laura M; Glenny, William et al. (2016) Abiotic and biotic factors affecting the replication and pathogenicity of bee viruses. Curr Opin Insect Sci 16:14-21
Di Cesare Mannelli, Lorenzo; Micheli, Laura; Cinci, Lorenzo et al. (2016) Effects of the neutrophil elastase inhibitor EL-17 in rat adjuvant-induced arthritis. Rheumatology (Oxford) 55:1285-94
Manlove, Kezia; Cassirer, E Frances; Cross, Paul C et al. (2016) Disease introduction is associated with a phase transition in bighorn sheep demographics. Ecology 97:2593-2602
Schepetkin, Igor A; Khlebnikov, Andrei I; Kirpotina, Liliya N et al. (2016) Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives. Int Immunopharmacol 37:43-58
Vergelli, Claudia; Schepetkin, Igor A; Ciciani, Giovanna et al. (2016) Synthesis of Five- and Six-Membered N-Phenylacetamido Substituted Heterocycles as Formyl Peptide Receptor Agonists. Drug Dev Res :

Showing the most recent 10 out of 64 publications